Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross‐over study

Aims/Introduction We compared the efficacy and safety of insulin glargine 300 U/mL (Gla300) and insulin degludec U100 (Deg) using a flash glucose monitoring system. Materials and Methods A total of 24 Japanese patients with type 2 diabetes were randomized to receive once‐daily Gla300 (n = 12) or Deg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes investigation 2019-03, Vol.10 (2), p.352-357
Hauptverfasser:	Yamabe, Mizuho, Kuroda, Mami, Hirosawa, Yasuyo, Kamino, Hiromi, Ohno, Haruya, Yoneda, Masayasu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers - analysis Blood Glucose - analysis Blood Glucose Self-Monitoring - methods Clinical Trial Cross-Over Studies Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Female Flash glucose monitoring Follow-Up Studies Glucose Glucose monitoring Glycated Hemoglobin A - analysis Humans Hypoglycemia Hypoglycemic Agents - therapeutic use Insulin Insulin degludec Insulin Glargine - therapeutic use Insulin glargine 300 U/mL Insulin, Long-Acting - therapeutic use Male Metformin Prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims/Introduction We compared the efficacy and safety of insulin glargine 300 U/mL (Gla300) and insulin degludec U100 (Deg) using a flash glucose monitoring system. Materials and Methods A total of 24 Japanese patients with type 2 diabetes were randomized to receive once‐daily Gla300 (n = 12) or Deg (n = 12) in the morning. The primary end‐points were the mean percentage of time in the target glucose range (70–179 mg/dL) and hypoglycemia (
ISSN:	2040-1116 2040-1124
DOI:	10.1111/jdi.12894